Genelux Corporation
Genelux Corporation
GNLX
Valuace
70
Růst
0
Zdraví
50
Cena
$ 5.94
Dnes
+0.18 (7.03%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-171%
ROA
-128%
PE
-3
PS
11153
Cena 1R
2-9
⌀ Cena
3.84
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
06-04-2026
Poslední dividenda

Profil

Genelux Corporation, biofarmaceutická společnost působící v klinickém stadiu, se zaměřuje na vývoj nové generace onkolytických virových imunoterapií pro pacienty trpící agresivními a/nebo obtížně léčitelnými solidními typy nádorů. Jeho hlavním kandidátem je Olvi-Vec, patentovaný modifikovaný kmen viru vakcíny určený k léčbě ovariálního karcinomu a nemalobuněčného karcinomu plic. Společnost také vyvíjí V2ACT imunoterapii pro léčbu rakoviny slinivky břišní; a V-VET1 pro léčbu hematologického a solidního karcinomu. Společnost byla založena v roce 2001 a sídlí ve Westlake Village v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
24
Založení
2023-01-26
Adresa
2625 Townsgate Road
CEO
Thomas Zindrick

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020
Total Revenues8.008.008.00170.0011,068.000.000.00
Cost of Revenues291.00574.00903.001,018.000.000.000.00
Gross Profit-283.00-566.00-895.00-848.0011,068.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues8.000.000.000.000.000.000.008.001,464.000.00
Cost of Revenues148.000.00143.000.000.000.00204.00248.00201.00272.00
Gross Profit-140.000.00-143.000.000.000.00-204.00-240.001,263.00-272.00
Operating Income TTM 202520242023202220212020
R&D Expenses0.000.000.0012,767.009,078.006,319.006,227.00
Selling General & Admin Expenses0.000.000.0011,568.005,003.008,294.006,195.00
Depreciation & Amortization0.00574.00903.001,018.00968.00497.00658.00
Total Operating Expenses32,931.0032,648.0030,801.0024,335.0014,081.0014,613.0012,422.00
Operating Income-33,214.00-33,214.00-31,696.00-24,165.00-3,013.00-14,613.00-12,422.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.004,160.002,819.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.002,640.002,488.00
Depreciation & Amortization-426.00144.00143.00139.00227.00224.00204.00248.00201.00272.00
Total Operating Expenses9,272.008,194.007,649.007,816.009,748.006,941.006,688.007,875.006,800.005,307.00
Operating Income-9,412.00-8,194.00-7,792.00-7,816.00-9,748.00-6,941.00-6,892.00-8,115.00-7,001.00-5,307.00
Net Income TTM 202520242023202220212020
Interest Income1,069.001,069.001,457.00244.000.000.000.00
Interest Expense0.000.000.003,974.001,408.001,417.001,221.00
Other Expense1,069.001,069.001,827.00-4,132.00-1,094.00-1,765.00-1,221.00
IBT-32,145.00-32,145.00-29,869.00-28,297.00-4,107.00-16,378.00-13,643.00
Income Tax Expense0.000.000.000.001,100.001,417.001,221.00
Net Income-32,145.00-32,145.00-29,869.00-28,297.00-5,207.00-17,795.00-14,864.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income165.00244.00336.00324.00402.00474.00316.00265.00240.004.00
Interest Expense0.000.000.000.000.000.000.000.006.0042.00
Other Expense165.00244.00336.00324.00772.00474.00316.00265.00234.00-38.00
IBT-9,247.00-7,950.00-7,456.00-7,492.00-8,976.00-6,467.00-6,576.00-7,850.00-6,767.00-5,345.00
Income Tax Expense0.000.000.000.000.000.000.000.00-4,031.00-38.00
Net Income-9,247.00-7,950.00-7,456.00-7,492.00-8,976.00-6,467.00-6,576.00-7,850.00-6,767.00-5,345.00
Per Share Data TTM 202520242023202220212020
EPS$0.00$0.00$0.00$-1.16$-0.57$-0.84$-0.63
EPS Diluted$0.00$0.00$0.00$-1.16$-0.57$-0.75$-0.63
Shares Outstanding37,176.5337,176.5331,450.7324,429.289,116.4921,101.7423,647.44
Diluted Shares Outstanding37,176.5337,176.5331,450.7324,429.289,116.4923,647.4423,647.44
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.25$-0.20
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.25$-0.20
Shares Outstanding37,176.5337,893.3137,946.3334,926.0831,450.7334,532.3629,689.3426,849.7426,788.9926,657.91
Diluted Shares Outstanding37,176.5337,893.3137,946.3334,926.0831,450.7334,532.3629,689.3426,849.7426,788.9926,657.91
Current Assets TTM 20242023202220212020
Cash And Equivalents7,858.008,565.009,418.00397.004,495.0011,350.00
Short Term Investments25,778.0022,330.0013,773.000.000.000.00
Total Cash & ST Investments33,636.0030,895.0023,191.00397.004,495.0011,350.00
Accounts Receivable0.000.000.000.000.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets1,234.00653.001,012.001,495.000.000.00
Total Current Assets34,870.0031,548.0024,203.001,892.005,822.0011,477.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents4,692.006,546.0016,206.008,565.006,102.007,858.004,061.009,418.0029,869.0027,140.00
Short Term Investments16,223.0021,426.0018,896.0022,330.0027,955.0025,778.0015,566.0013,773.000.000.00
Total Cash & ST Investments20,915.0027,972.0035,102.0030,895.0034,057.0033,636.0019,627.0023,191.0029,869.0027,140.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets637.001,263.00843.00653.001,910.001,234.001,577.001,012.001,310.001,543.00
Total Current Assets21,552.0029,235.0035,945.0031,548.0035,967.0034,870.0021,204.0024,203.0031,179.0028,683.00
Long-Term Assets TTM 20242023202220212020
Net Property, Plant & Equipment3,404.003,076.003,598.001,979.002,212.002,451.00
Goodwill0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Long-Term Investments6,813.000.000.000.000.000.00
Other Long-Term Assets92.0092.0092.001,660.0092.0080.00
Total Long-Term Assets10,309.003,168.003,690.003,639.002,304.002,531.00
Total Assets45,179.0034,716.0027,893.005,531.008,126.0014,008.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment3,312.002,939.002,967.003,076.003,208.003,404.003,380.003,598.002,801.002,588.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.001,003.006,813.000.000.000.000.00
Other Long-Term Assets123.0073.0073.0092.0092.0092.0092.0092.0092.0092.00
Total Long-Term Assets3,435.003,012.003,040.003,168.004,303.0010,309.003,472.003,690.002,893.002,680.00
Total Assets24,987.0032,247.0038,985.0034,716.0040,270.0045,179.0024,676.0027,893.0034,072.0031,363.00
Current Liabilities TTM 20242023202220212020
Accounts Payable4,786.005,570.003,784.006,775.004,462.003,708.00
Short-Term Debt500.00329.001,306.0016,665.006,557.003,890.00
Other Current Liabilities517.001,004.001,464.008,016.006,964.006,895.00
Current Liabilities5,803.006,903.006,554.0031,626.0022,483.0014,493.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.006,033.006,688.005,570.004,454.004,786.005,313.003,784.004,009.004,484.00
Short-Term Debt354.00345.00337.00329.00415.00500.00584.001,306.001,174.001,235.00
Other Current Liabilities4,772.00610.00664.001,004.00686.00517.001,908.001,464.003,572.002,159.00
Current Liabilities5,126.006,988.007,689.006,903.005,555.005,803.007,805.006,554.008,755.007,878.00
Long-Term Liabilities TTM 20242023202220212020
Long-Term Debt1,707.001,539.001,866.009,688.0018,754.0022,170.00
Capital Leases1,707.001,868.002,519.001,430.001,133.00761.00
Def. Tax Liability0.000.000.000.000.000.00
Total Liabilities7,510.008,442.008,420.0041,314.0041,237.0036,663.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt1,270.001,361.001,450.001,539.001,624.001,707.001,787.001,866.001,289.001,229.00
Capital Leases1,624.001,706.001,787.001,868.002,039.002,207.002,371.001,866.001,856.001,814.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities6,396.008,349.009,139.008,442.007,179.007,510.009,592.008,420.0010,044.009,107.00
Total Common Equity TTM 20242023202220212020
Common Stock35.0035.0027.009.009.009.00
Retained Earnings-235,950.00-251,393.00-221,524.00-189,784.00-184,577.00-168,228.00
Comprehensive Income-11.0064.0014.002.002.002.00
Total Common Equity37,669.0026,274.0019,473.00-35,783.00-33,111.00-22,655.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock38.0038.0038.0035.0035.0035.0027.0027.0027.0026.00
Retained Earnings-274,291.00-266,341.00-258,885.00-251,393.00-242,417.00-235,950.00-229,374.00-221,524.00-214,757.00-209,412.00
Comprehensive Income8.003.0029.0064.00124.00-11.00-5.0014.002.002.00
Total Common Equity18,591.0023,898.0029,846.0026,274.0033,091.0037,669.0015,084.0019,473.0024,028.0022,256.00
Other TTM 20242023202220212020
Total Debt2,207.001,868.002,519.0026,353.0025,311.0026,060.00
Book Value37,669.0026,274.0019,473.00-35,783.00-33,111.00-22,655.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value18,591.0023,898.0029,846.0026,274.0033,091.0037,669.0015,084.0019,473.0024,028.0022,256.00
Cash Flow From Operating Activities TTM 202520242023202220212020
Net Income-26,538.00-32,145.00-29,869.00-28,297.00-5,207.00-16,378.00-13,643.00
Depreciation & Amortization925.00244.00903.001,018.00968.00895.00658.00
Stock-Based Compensation5,202.005,871.006,070.005,204.002,415.004,271.005,325.00
Change Working Capital-2,148.00-1,046.00751.00-3,281.00-1,691.004,083.00381.00
Change In Accounts Receivable0.000.000.000.000.000.000.00
Change In Accounts Payable302.00-1,213.002,156.00-2,358.002,313.00754.00-126.00
Change In Inventories0.000.000.000.000.000.000.00
Other Non-cash Items6,263.001,808.00917.002,723.00-56.00196.0074.00
Cash from Operations-21,445.000.000.00-20,275.00-3,571.00-6,585.00-7,205.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-9,247.00-7,950.00-7,456.00-7,492.00-8,976.00-6,467.00-6,576.00-7,850.00-6,767.00-5,345.00
Depreciation & Amortization135.00144.00-174.00139.00227.00-830.00204.00248.00201.00272.00
Stock-Based Compensation810.002,348.001,284.001,429.001,430.001,201.001,304.001,803.001,555.00540.00
Change Working Capital1,015.00-1,376.00-1,211.00526.002,890.001,132.00-1,739.00607.00-2,003.00987.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable374.00-2,040.00-665.001,118.001,816.00-662.00-527.001,529.00-225.00-475.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items1,088.00259.00498.00-37.00127.00-784.00-17.00838.002,286.00147.00
Cash from Operations0.000.000.000.000.000.000.000.00-6,910.00-3,357.00
Cash Flow From Investing Activities TTM 202520242023202220212020
Capital Expenditure-778.00-1,098.00-381.00-1,025.00-49.000.00-20.00
Acquisitions0.000.000.000.000.000.000.00
Investments-40,238.00-18,261.00-29,000.00-13,699.000.000.000.00
Sales of Investment8,000.0031,500.0021,250.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.00
Cash from Investing-33,016.000.000.00-14,724.00-49.000.00-20.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-436.00-517.00-115.00-30.00-96.00-27.00-228.00-30.00-243.00-277.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments0.00-5,262.00-10,538.00-2,461.00-480.00-1,981.00-23,378.00-3,161.00-13,699.000.00
Sales of Investment7,000.0010,500.008,000.006,000.007,250.006,000.006,500.001,500.000.000.00
Other Investing Activities0.000.000.000.000.000.000.000.000.000.00
Cash from Investing0.000.000.000.000.000.000.000.00-13,942.00-277.00
Cash Flow From Financing Activities TTM 202520242023202220212020
Debt Repaid-710.000.000.00215.00-130.00-1,495.00-2,900.00
Debt Issued1,038.001,868.00-651.00-23,619.001,172.00746.0028,960.00
Issuance of Common Stock32,316.000.000.0039,645.00120.00143.008,989.00
Repurchase of Common Stock0.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.00
Other Financing Activities29,804.000.000.004,160.00-468.001,082.0012,061.00
Cash from Financing35,179.000.000.0044,020.00-478.00-270.0018,150.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.00-25.00
Debt Issued1,624.00-82.00-81.00-81.00-171.00-168.00-164.00-148.00623.0042.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00401.003,500.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00401.002,888.00
Cash from Financing0.000.000.000.000.000.000.000.00401.006,363.00
Cash position TTM 202520242023202220212020
Net Change in Cash-19,282.00-3,232.00-853.009,021.00-4,098.00-6,855.0010,925.00
Closing Cash Balance7,858.005,333.008,565.009,418.00397.004,495.0011,350.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash641.00-1,854.00-9,660.007,641.002,463.00-1,756.003,797.00-5,357.00-20,451.002,729.00
Closing Cash Balance5,333.004,692.006,546.0016,206.008,565.006,102.007,858.004,061.009,418.0029,869.00
Free Cash Flow TTM 202520242023202220212020
Free Cash Flow-22,223.00-26,366.00-21,609.00-21,300.00-3,620.00-6,585.00-7,225.00
Real Free Cash Flow-27,425.00-32,237.00-27,679.00-26,504.00-6,035.00-10,856.00-12,550.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-6,635.00-7,092.00-7,174.00-5,465.00-4,398.00-5,775.00-7,052.00-4,384.00-7,153.00-3,634.00
Real Free Cash Flow-7,445.00-9,440.00-8,458.00-6,894.00-5,828.00-6,976.00-8,356.00-6,187.00-8,708.00-4,174.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-2.8-11.6-1.4
P/S11153628.89.4
P/B4.823.95.2
P/FCF-2.8-11.5-1.5
Market cap$0.2$0.1
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets6.5 %155.5 %0 %
Debt to Income-5.1 %-91.5 %0 %
Debt to Free cash flow-5 %-625 %0 %
Interest expense percentage0 %-11.1 %44.7 %
Current ratio4.2 2.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-172.9 %-15.9 %0 %
ROA-128.6 %-219.9 %0 %
CapEx to Revenue0 %30.2 %0 %
RaD to Revenue0 %703.9 %0 %
ROEM333.3 117779.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %8.7 %68.7 %
Operating margin0 %-1195.7 %35.5 %
Net margin0 %-1356.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding37.9 mil 26.9 mil
Employee count0.0 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader